Mol. Pharmaceutics 2025, 22, 1, 5–27
Tannergren C, Arora S, Babiskin A, Borges L, Chatterjee P, Cheng YH, Dallmann A, Govada A, Heimbach T, Hingle M, Kollipara S, Kotzagiorgis E, Lindahl A, Mackie C, Malamatari M, Mitra A, Moody R, Pepin X, Polli J, Raines K, Rullo G, Sanghavi M, Savkur R, Singh R, Sjögren E, Suarez-Sharp S, Thomas S, Veerasingham S, Wei K, Wu F, Xu Y, Yoon M, Rege B
.webp?width=660&height=660&name=16cefda6ef73b7faa4df913b326b6999f7619968%20(1).webp)
.webp?width=660&height=660&name=b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f%20(1).webp)
.webp?width=660&height=660&name=4033665f49ccf946b5c8406d016bbcdc6e406076%20(1).webp)